Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study von van Imhoff, Gustaaf W, McMillan, Andrew, Matasar, Matthew J, Radford, John, Ardeshna, Kirit M, Kuliczkowski, Kazimierz, Kim, WonSeog, Hong, Xiaonan, Goerloev, Jette Soenderskov, Davies, Andrew, Barrigón, María Dolores Caballero, Ogura, Michinori, Leppä, Sirpa, Fennessy, Michael, Liao, Qiming, van der Holt, Bronno, Lisby, Steen, Hagenbeek, Anton

Volltext

Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study von Kalashnikov, Ilja, Tanskanen, Tomas, Viisanen, Leevi, Malila, Nea, Jyrkkiö, Sirkku, Leppä, Sirpa

Volltext

Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment von Autio, Matias, Leivonen, Suvi-Katri, Brück, Oscar, Karjalainen-Lindsberg, Marja-Liisa, Pellinen, Teijo, Leppä, Sirpa

Volltext

PD-L1 + tumor-associated macrophages and PD-1 + tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma von Pollari, Marjukka, Brück, Oscar, Pellinen, Teijo, Vähämurto, Pauli, Karjalainen-Lindsberg, Marja-Liisa, Mannisto, Susanna, Kallioniemi, Olli, Kellokumpu-Lehtinen, Pirkko-Liisa, Mustjoki, Satu, Leivonen, Suvi-Katri, Leppä, Sirpa

Volltext

A High Tumor-Associated Macrophage Content Predicts Favorable Outcome in Follicular Lymphoma Patients Treated with Rituximab and Cyclophosphamide-Doxorubicin-Vincristine-Prednisone von TASKINEN, Minna, KARJALAINEN -LINDSBERG, Marja-Liisa, NYMAN, Heidi, EEROLA, Leena-Maija, LEPPÄ, Sirpa

Volltext

Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma von Crump, Michael, Leppä, Sirpa, Fayad, Luis, Lee, Je Jung, Di Rocco, Alice, Ogura, Michinori, Hagberg, Hans, Schnell, Frederick, Rifkin, Robert, Mackensen, Andreas, Offner, Fritz, Pinter-Brown, Lauren, Smith, Sonali, Tobinai, Kensei, Yeh, Su-Peng, Hsi, Eric D, Nguyen, Tuan, Shi, Peipei, Hahka-Kemppinen, Marjo, Thornton, Don, Lin, Boris, Kahl, Brad, Schmitz, Norbert, Savage, Kerry J, Habermann, Thomas

Volltext

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma von Meriranta, Leo, Alkodsi, Amjad, Pasanen, Annika, Lepistö, Maija, Mapar, Parisa, Blaker, Yngvild Nuvin, Jørgensen, Judit, Karjalainen-Lindsberg, Marja-Liisa, Fiskvik, Idun, Mikalsen, Lars Tore G., Autio, Matias, Björkholm, Magnus, Jerkeman, Mats, Fluge, Øystein, Brown, Peter, Jyrkkiö, Sirkku, Holte, Harald, Pitkänen, Esa, Ellonen, Pekka, Leppä, Sirpa

Volltext

Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes von Alkodsi, Amjad, Cervera, Alejandra, Zhang, Kaiyang, Louhimo, Riku, Meriranta, Leo, Pasanen, Annika, Leivonen, Suvi-Katri, Holte, Harald, Leppä, Sirpa, Lehtonen, Rainer, Hautaniemi, Sampsa

Volltext

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: result... von Pulczynski, Elisa J, Kuittinen, Outi, Erlanson, Martin, Hagberg, Hans, Fosså, Alexander, Eriksson, Mikael, Nordstrøm, Marie, Østenstad, Bjørn, Fluge, Øystein, Leppä, Sirpa, Fiirgaard, Bente, Bersvendsen, Hanne, Fagerli, Unn-Merete

Volltext

Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma von Karihtala, Kristiina, Leivonen, Suvi-Katri, Bruck, Oscar, Karjalainen-Lindsberg, Marja-Liisa, Mustjoki, Satu, Pellinen, Teijo, Leppa, Sirpa

Volltext

Testicular Diffuse Large B-Cell Lymphoma-Clinical, Molecular, and Immunological Features von Pollari, Marjukka, Leivonen, Suvi-Katri, Leppa, Sirpa

Volltext

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in p... von Falchi, Lorenzo, Hutchings, Martin, Carlo-Stella, Carmelo, Morschhauser, Franck, Dickinson, Michael, Cartron, Guillaume, Khan, Cyrus, Tani, Monica, Martinez-Lopez, Joaquin, Bartlett, Nancy L, Salar, Antonio, Brody, Joshua D, Leppä, Sirpa, Berthier, Aurelien, Kallemeijn, Martine, Relf, James, Tchaleu, Fabiola Bene, Lundberg, Linda, Bachy, Emmanuel

Volltext

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy von Nyman, Heidi, Adde, Magdalena, Karjalainen-Lindsberg, Marja-Liisa, Taskinen, Minna, Berglund, Mattias, Amini, Rose-Marie, Blomqvist, Carl, Enblad, Gunilla, Leppä, Sirpa

Volltext

Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma von Meriranta, Leo, Pasanen, Annika, Alkodsi, Amjad, Haukka, Jari, Karjalainen-Lindsberg, Marja-Liisa, Leppä, Sirpa

Volltext

EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways von Kajanne, Risto, Miettinen, Päivi, Mehlem, Annika, Leivonen, Suvi-Katri, Birrer, Michael, Foschi, Marco, Kähäri, Veli-Matti, Leppä, Sirpa

Volltext

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy von Riihijärvi, Sari, Taskinen, Minna, Jerkeman, Mats, Leppä, Sirpa

Volltext

Low lymphocyte‐to‐monocyte ratio predicts poor outcome in high‐risk aggressive large B‐cell lymphoma von Vajavaara, Heli, Leivonen, Suvi‐Katri, Jørgensen, Judit, Holte, Harald, Leppä, Sirpa

Volltext

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R‐POLA‐MINI‐CHP AND R‐MINI‐CHOP von Jerkeman, Mats, Leppä, Sirpa, Hamfjord, Julian, Brown, Peter, Ekberg, Sara, José María Ferreri, Andrés

Volltext

Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma von Vajavaara, Heli, Mortensen, Julie Bondgaard, Leivonen, Suvi-Katri, Hansen, Ida Monrad, Ludvigsen, Maja, Holte, Harald, Jorgensen, Judit, Bjerre, Mette, d'Amore, Francesco, Leppa, Sirpa

Volltext

Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells von KAJANNE, Risto, MIETTINEN, Päivi, TENHUNEN, Mikko, LEPPÄ, Sirpa

Volltext